NCT04440072

Brief Summary

Continuous Doppler ankle brachial index (ABI) is the gold standard for screening and monitoring of peripheral arterial disease (PAD) but is no longer carried out in clinical practice. The recommended measurement was gradually replaced by colour or pulsed Doppler without validation of these techniques. The objective of our study is to compare these two techniques (color Doppler and pulsed Doppler in echodoppler) with respect to the gold standard (continuous Doppler) for ABI measurement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 19, 2020

Completed
28 days until next milestone

Study Start

First participant enrolled

July 17, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2021

Completed
Last Updated

July 20, 2020

Status Verified

July 1, 2020

Enrollment Period

11 months

First QC Date

June 17, 2020

Last Update Submit

July 17, 2020

Conditions

Keywords

ankle brachial indexcolor duplex ultrasoundpulsed doppler

Outcome Measures

Primary Outcomes (1)

  • Concordance on the IPS value measured with pulsed Doppler compared to gold standard

    30 minutes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient referred to the Vascular Medicine Department for a vascular examination with ABI measurement. In most cases, these patients present with symptoms suggestive of PAD, most often with vascular risk factors for atherosclerosis.

You may qualify if:

  • Patient referred to the Vascular Medicine Department of Caen University Hospital for a vascular examination with ABI measurement having been informed and not objecting to participation in the study and benefiting from a social protection system.

You may not qualify if:

  • Patient with arrhythmia
  • Patient with trans-tibial or more proximal amputation
  • Patient with extensive trophic disorder not allowing measurement
  • Patient with subgonal bypass
  • Known bilateral sub-clavian stenoses
  • Patient deprived of liberty or under a measure of legal protection
  • Interned patient for the treatment of a psychiatric or physical illness
  • Patients who are legally incompetent, under the protection of justice, under guardianship or trusteeship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Caen

Caen, France

RECRUITING

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Central Study Contacts

Direction de la recherche et de l'enseignement

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2020

First Posted

June 19, 2020

Study Start

July 17, 2020

Primary Completion

June 22, 2021

Study Completion

June 22, 2021

Last Updated

July 20, 2020

Record last verified: 2020-07

Locations